Plasmapheresis in the Treatment of Refractory Myoclonic Status. A Case Report

1Helms J, Kremer S., Merdji H, et al. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med 2020; 382:22682270. Helms J Kremer S. Merdji H et al Neurologic Features in Severe SARS-CoV-2 Infection N Engl J Med 2020 3822268227010.1056/NEJMc2008597717996732294339Search in Google Scholar

2Oxley T., Mocco J., Majidi S., et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Engl J Med 2020;382:e60 Oxley T. Mocco J. Majidi S. et al Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young N Engl J Med 2020382e6010.1056/NEJMc2009787720707332343504Search in Google Scholar

3Rábano-Suárez P., Bermejo-Guerrero L., Méndez-Guerrero A., et al. Generalized myoclonus in COVID-19. Neurology 2020;95(6): e767-e772 Rábano-Suárez P. Bermejo-Guerrero L. Méndez-Guerrero A. et al Generalized myoclonus in COVID-19 Neurology 202095 6 e767 e77210.1212/WNL.0000000000009829745536032439821Search in Google Scholar

4Mancuso E, Tanzi G. Paradoxical Reactions to Benzodiazepines: Literature Review and Treatment Options. Pharmacotherapy. 2004;24(9):1177-85. Mancuso E Tanzi G Paradoxical Reactions to Benzodiazepines: Literature Review and Treatment Options Pharmacotherapy 200424 9 1177–8510.1592/phco.24.13.1177.3808915460178Search in Google Scholar

5Lee H, Lee J. Lance-Adams Syndrome. Annals of Rehabilitation Medicine. 2011;35:939. Lee H Lee J Lance-Adams Syndrome Annals of Rehabilitation Medicine 20113593910.5535/arm.2011.35.6.939330936722506225Search in Google Scholar

6Rice J, Nagle S, Randall J, et al. Chimeric Antigen Receptor T Cell-Related Neurotoxicity: Mechanisms, Clinical Presentation, and Approach to Treatment. Curr Treat Options Neurol. 2019;21(8):40. Rice J Nagle S Randall J et al Chimeric Antigen Receptor T Cell-Related Neurotoxicity: Mechanisms, Clinical Presentation, and Approach to Treatment Curr Treat Options Neurol 201921 8 4010.1007/s11940-019-0580-331327064Search in Google Scholar

7Santomasso BD, Park JH, Salloum D, et al. Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukaemia. Cancer Discov. 2018;8:958–71. Santomasso BD Park JH Salloum D et al Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukaemia Cancer Discov 20188958 7110.1158/2159-8290.CD-17-1319638559929880584Search in Google Scholar

8Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473‐4 Moore JB June CH Cytokine release syndrome in severe COVID-19 Science 2020368 6490 473‐410.1126/science.abb892532303591Search in Google Scholar

9Kabaka N, Taskin E, Aydin M. Segmental myoclonus as the presenting symptom of an acute disseminated encephalomyelitis: a case report. Eur J Paediatr Neurol. 2006;10(1):45-8 Kabaka N Taskin E Aydin M Segmental myoclonus as the presenting symptom of an acute disseminated encephalomyelitis: a case report Eur J Paediatr Neurol 200610 1 45–810.1016/j.ejpn.2005.11.00816530437Search in Google Scholar

10Siddiqui HK, Mehra MR. COVID-19 Illness in Native and Immunosuppressed States: A ClinicalTherapeutic Staging Proposal. J Heart Lung Transplant. 2020 May;39(5):405-7. Siddiqui HK Mehra MR COVID-19 Illness in Native and Immunosuppressed States: A ClinicalTherapeutic Staging Proposal J Heart Lung Transplant 2020 May 39 5 405–710.1016/j.healun.2020.03.012711865232362390Search in Google Scholar